These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16937554)

  • 1. HIV Variants and Hepatitis B Surface Antigen Mutants. Proceedings of a symposium, May 22-24, 2005, Washington, DC, USA.
    J Med Virol; 2006; 78 Suppl 1():S1-70. PubMed ID: 16937554
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays.
    Schochetman G; Kuhns MC
    J Med Virol; 2006; 78 Suppl 1():S3-6. PubMed ID: 16622869
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV variants and hepatitis B surface antigen mutants.
    Zuckerman AJ
    J Med Virol; 2006; 78 Suppl 1():S1-2. PubMed ID: 16622868
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance for hepatitis B surface antigen mutants.
    Coleman PF
    J Med Virol; 2006; 78 Suppl 1():S56-8. PubMed ID: 16622879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting hepatitis B surface antigen mutants.
    Coleman PF
    Emerg Infect Dis; 2006 Feb; 12(2):198-203. PubMed ID: 16494742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide and amino acid diversity of hepatitis B virus surface antigen in acute infections, southeastern France.
    Petit PR; Borentain P; Aherfi S; Benezech A; Botta-Fridlund D; Tamalet C; Motte A; Gerolami R; Colson P
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):e32-e34. PubMed ID: 28927658
    [No Abstract]   [Full Text] [Related]  

  • 7. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection.
    Hamkar R; Aghakhani A; Soufian S; Banifazl M; Ghavami N; Nadri M; Sofian M; Ahmadi F; Razeghi E; Eslamifar A; Ramezani A
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):285-91. PubMed ID: 19903586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis B virus mutants on efficacy of vaccination.
    Zuckerman AJ
    Lancet; 2000 Apr; 355(9213):1382-4. PubMed ID: 10791517
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular epidemiology of hepatitis B virus mutants.
    Zuckerman AJ; Zuckerman JN
    J Med Virol; 1999 Jul; 58(3):193-5. PubMed ID: 10447411
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient.
    Henke-Gendo C; Amini-Bavil-Olyaee S; Challapalli D; Trautwein C; Deppe H; Schulz TF; Heim A; Tacke F
    J Infect Dis; 2008 Dec; 198(11):1620-4. PubMed ID: 18847320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance.
    Locarnini SA
    Hepatology; 1998 Jan; 27(1):294-7. PubMed ID: 9425951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-HBs escape mutants--implication of neutralization escape and diagnostic escape].
    Okamoto H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():98-105. PubMed ID: 15453295
    [No Abstract]   [Full Text] [Related]  

  • 14. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting.
    Gerlich WH
    Intervirology; 2004; 47(6):310-3. PubMed ID: 15593449
    [No Abstract]   [Full Text] [Related]  

  • 17. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    La'ulu SL; Roberts WL
    Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horizontal transmission of a hepatitis B virus surface antigen mutant.
    Chen WN; Oon CJ; Koh S
    J Clin Microbiol; 2000 Feb; 38(2):938-9. PubMed ID: 10722322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
    Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
    Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis B viral mutation and its clinical significance].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():167-74. PubMed ID: 15453309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.